Clin2
NCT07265076Possibly a fitNot yet recruiting

Omega-6 fatty acids in liver cancer patients

Carcinoma, Hpatocellular

Part of Cancer clinical trials.

This study looks at omega-6 fatty acid levels in people with liver cancer compared to those without it, to see if they might affect the disease. It may help guide future treatments or ways to manage the condition.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 50 years
Study type
Observational

Who can take part

  • Age 18 or older
  • Diagnosed with hepatocellular carcinoma (a type of liver cancer)
  • Or a healthy person without liver disease or cancer (as a comparison group)
  • Or a person with liver cirrhosis (scarring of the liver) but no cancer
  • No other types of cancer or chronic inflammatory diseases
  • Not currently taking omega-3 or omega-6 supplements

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06623474Recruiting
Fat markers in blood for liver cancer study

This study is for people having liver cancer surgery. It will look at certain fats in your blood to see if they can help doctors understand and track liver cancer better.

Guangzhou, Guangdong
NCT06523179Recruiting
Liver cancer risk study for people with fatty liver disease

This study looks at your risk of developing liver cancer (hepatocellular carcinoma) if you have a liver condition such as NAFLD or a related disease. It aims to improve how doctors predict who might be at higher risk, so they can offer better monitoring and care.

Milan, Milano
NCT07840092Recruiting
Blood and tissue markers for liver cancer treatment response

This study looks at blood and tissue samples from people with liver cancer to find markers that can predict how well treatment works and whether the cancer might come back. It may help doctors personalize treatment and follow-up care.

Tianjin
NCT07119957Recruiting
Liver cancer study: chemical and social risk factors

This study looks at how chemicals in our environment and life stress might be linked to liver cancer. It is for people with fatty liver disease caused by metabolism or alcohol, who are having a liver biopsy.

Angers
NCT06864221Recruiting
How fat molecules in blood affect liver cancer radiotherapy

This study looks at whether certain fats in your blood can help predict how well radiotherapy works for liver cancer. If you are getting radiation for liver cancer, your blood samples may help doctors learn more about your treatment response.

Guangzhou, Guangdong
NCT06518434Recruiting· Phase 2
Cannabis oil for advanced liver cancer study

This study tests if cannabis oil can help people with advanced liver cancer that cannot be treated with standard therapies. It is a small pilot study to see if the oil is safe and may improve symptoms or quality of life.

Groningen

Hear when a new Carcinoma, Hpatocellular trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.